Lacinda Michelle Denis, PA

Lacinda Denis practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Lacinda Denis' NPI, 1235182601, was assigned on May 18, 2006. Lacinda Denis holds Florida license PA 9102449.

Lacinda Denis' primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Lacinda Denis' primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Lacinda Denis is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Lacinda Denis to 4 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lacinda Denis practices, 9 sites in all. Vendor and product names are available with a free account.

Physician assistant is Lacinda Denis' primary specialty in the NPI Registry, under taxonomy code 363A00000X. Lacinda Denis is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Lacinda Denis is licensed in Florida.

CMS data shows 31 Medicare services from Lacinda Denis across 1 procedure code in 2024, all of them office visits, for 58 Medicare patients. Medicare paid $1,875 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Lacinda Denis in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lacinda Denis' median patient age at 68, with 58% women.

In 2024, Lacinda Denis wrote 93 Medicare Part D claims for 47 patients. 98% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $319 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Lacinda Denis for performance year 2024, reported as part of a group. Lacinda Denis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lacinda Denis as offering telehealth.